Depression and coronary heart disease

RM Carney, KE Freedland - Nature Reviews Cardiology, 2017 - nature.com
Depression is a highly prevalent risk factor for incident coronary heart disease (CHD) and for
cardiovascular morbidity and mortality in patients with established CHD. Several biological …

Depression and cardiovascular disease: a clinical review

DL Hare, SR Toukhsati, P Johansson… - European heart …, 2014 - academic.oup.com
Cardiovascular disease (CVD) and depression are common. Patients with CVD have more
depression than the general population. Persons with depression are more likely to …

Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association

EP Havranek, MS Mujahid, DA Barr, IV Blair… - Circulation, 2015 - Am Heart Assoc
874 Circulation September 1, 2015 references are intended to be illustrative and to highlight
significant knowledge in the field. The premise underlying this scientific statement is that, at …

Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the …

JH Lichtman, ES Froelicher, JA Blumenthal… - Circulation, 2014 - Am Heart Assoc
Background—Although prospective studies, systematic reviews, and meta-analyses have
documented an association between depression and increased morbidity and mortality in a …

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and …

European Journal of Preventive Cardiology, 2012 - journals.sagepub.com
Atherosclerotic cardiovascular disease (CVD) is a chronic disorder develo** insidiously
throughout life and usually progressing to an advanced stage by the time symptoms occur. It …

Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice

CD Schetter, L Tanner - Current opinion in psychiatry, 2012 - journals.lww.com
This body of evidence, and the develo** consensus regarding biological and behavioral
mechanisms, sets the stage for a next era of psychiatric and collaborative interdisciplinary …

AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the …

SC Smith Jr, EJ Benjamin, RO Bonow, LT Braun… - Circulation, 2011 - Am Heart Assoc
(ACCF) guidelines on secondary prevention, 1 important evidence from clinical trials has
emerged that further supports and broadens the merits of intensive risk-reduction therapies …

The costs of depression

RC Kessler - The psychiatric Clinics of north America, 2011 - pmc.ncbi.nlm.nih.gov
Brief summary Data are reviewed on the societal costs of major depressive disorder (MDD).
Early-onset MDD is found to predict difficulties in subsequent role transitions, including low …

The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review

K Kroenke, RL Spitzer, JBW Williams, B Löwe - General hospital psychiatry, 2010 - Elsevier
BACKGROUND: Depression, anxiety and somatization are the most common mental
disorders in primary care as well as medical specialty populations; each is present in at least …

Major depressive disorder: new clinical, neurobiological, and treatment perspectives

DJ Kupfer, E Frank, ML Phillips - The Lancet, 2012 - thelancet.com
In this Seminar we discuss developments from the past 5 years in the diagnosis,
neurobiology, and treatment of major depressive disorder. For diagnosis, psychiatric and …